Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
N/A
-1,525,489 Closed
0 $0
Q3 2023

Feb 13, 2025

BUY
$98.98 - $115.74 $151 Million - $177 Million
1,525,489 New
1,525,489 $176 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Kite Lake Capital Management (Uk) LLP Portfolio

Follow Kite Lake Capital Management (Uk) LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kite Lake Capital Management (Uk) LLP, based on Form 13F filings with the SEC.

News

Stay updated on Kite Lake Capital Management (Uk) LLP with notifications on news.